Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCjMedical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Follow me on Twitter: